Download presentation
Presentation is loading. Please wait.
Published bySilas Martin Modified over 8 years ago
1
Effect of some adrenergic drugs and its blockers on the blood pressure
2
HTN is the most common cardiovascular disease. HTN was found in 29% of American adults. 60- 80 % of men and women will develop HTN by age 80 Uncontrolled BP damages blood vessels in kidney, heart, and brain.
4
BP= CO × PR Cardiac Output (Q) = SV × HR HR is Heart Rate, expressed as BPM (Beats Per Minute) Total Peripheral Resistance = (Mean Arterial Pressure - Mean Venous Pressure) / Cardiac OutputMean Arterial PressureMean Venous PressureCardiac Output
5
85 – 90 % essential HTN (no specific cause) 10 – 15 % secondary HTN ( specific cause)
6
Resistance ( Arterioles ) Capacitance (Venules) Pump output (Heart) Volume (Kidney)
8
1. Diuretics 2. Adrenergic receptor antagonists 3. Calcium channel blockers 4. Renin Inhibitors 5. ACE inhibitors 6. Angiotensin II receptor antagonists 7. Aldosterone antagonists 8. Vasodilators 9. Alpha-2 agonists 10. Positive Inotropes.
9
Loop diuretics: eg. Furosemide Loop diuretics Thiazide diuretics: eg. hydrochlorothiazide Thiazidehydrochlorothiazide Thiazide-like diuretics: eg. indapamideindapamide Potassium-sparing diuretics: eg. triamterene Potassium-sparing diureticstriamterene
10
Spironolactone
11
1. Beta blockers: Beta blockers Non selective beta1 (Propranolol) Selective beta1 (Atenolol) 2. Alpha blockers: (Prazosin) 3. Mixed alpha and beta blockers: (carvedilol)
12
1. Dihydropyridines: Amlodipine Nifedipine 2. Non- dihydropyridines (cardio selective): Verapamil Diltiazem
13
Aliskiren
14
Captopril Enalapril fosinopril
15
Candesartan Valsartan
16
act directly on the smooth muscle of arteries to relax their walls Sodium nitroprusside ( arteries, veins) Hydralazine (arteries)
17
by stimulating alpha-receptors in the brain Clonidine Methyldopa
18
Digoxin $ vagal nerve leading to bradycardia and AV block in high dose Used to treat atrial fib. WHY? And to treat C.H.F. because inhibits Na/K pump.
Similar presentations
© 2024 SlidePlayer.com. Inc.
All rights reserved.